Pharmafile Logo

We’re Celebrating Ten Magical Years for Ify at Lucid Group

- PMLiVE

Today we are celebrating a very important work anniversary for Ify Onyeaso. Ify joined Lucid 10 years ago, quickly becoming a core member of the then, fledgeling business. Over the last 10 years, she has shown the most amazing levels of commitment and dedication and has truly been a key part of the tremendous success and growth of Lucid Group. In her earlier Lucid days, Ify quickly established herself as an absolute Rockstar, throwing herself into the ‘fear zone’ regularly to help Lucid build its reputation as a true pioneer. She has been a key driver of Lighthouse’s growth since making the move over the pond four years ago and she continues to wow clients daily.

Lisa Druce, Managing Director, Lighthouse Medical Communications US commented, “ Ify is truly at the heart of the Lighthouse culture, her infectious laugh and sense of humour always brightens up the day. While I’ve only had the pleasure of working with Ify for just over one year, our paths crossed before she joined the Lucid Group and she has gone on to fully realise the wonderful talent that was evident back then. Congratulations Ify, looking forward to working with you for the next 10 years!”

Dennis O’Brien, Lucid Group CEO commented, “I’ve had the pleasure of seeing Ify grow and develop as a person and a colleague. I remember her first pitch, I remember when she facilitated an advisory board for the first time. Always fearless, always committed, always positive. I am proud to say we have an organisation that has people like Ify in it. Thank you.”

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid celebrate big wins at PMEA 2015

Success for Lucid at PMEA 2015

Lucid invests in their Futures programme with a new hire

Lucid Group continues their expansion

Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015

Rheumatologists eagerly await trial data for Janus kinase inhibitors

Making a difference to patients with IBD

Changing lives with medical education

Lucid Group showcases new KOL identification and mapping tool

Advancing Expert identification with digital new tool from Lucid Group

Lucid CEO discusses his inspiration and passion for changing patients’ lives

Changing patients' lives with innovative methodologies in medical education

Lucid Group starts new trend for CME in IBD education

A tailored educational event in IBD